Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 150,018 | 202,079 | 175,796 | 116,361 | 157,495 |
| Depreciation Amortization | 106,666 | 100,352 | 86,576 | 101,225 | 71,409 |
| Income taxes - deferred | 13,463 | -30,245 | -29,921 | 1,659 | -8,659 |
| Accounts receivable | -40,285 | -34,243 | -5,478 | -88,299 | 80,225 |
| Other Working Capital | -99,893 | -74,827 | 62,971 | -145,747 | -61,490 |
| Other Operating Activity | 178,300 | 99,401 | 14,045 | 226,826 | -279,551 |
| Operating Cash Flow | $308,269 | $262,517 | $303,989 | $212,025 | $-40,571 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -126,332 | -162,944 | -12,768 | 63,287 | 384,143 |
| PPE Investments | -38,730 | -151,359 | -87,466 | -73,384 | -35,504 |
| Net Acquisitions | N/A | 1,269 | -5,500 | N/A | -542,106 |
| Purchase Of Investment | -17,819 | N/A | N/A | -11,001 | -17,807 |
| Sale Of Investment | 5,381 | 13,500 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -29,838 | -179,609 | -124,407 | -28,382 | -18,645 |
| Other Investing Activity | -29,429 | -176,130 | -121,068 | -32,110 | -17,481 |
| Investing Cash Flow | $-206,929 | $-475,664 | $-226,802 | $-53,208 | $-228,755 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 60,000 | N/A | N/A | N/A |
| Debt Issued | N/A | 560,625 | N/A | 6,700 | 501,000 |
| Debt Repayment | -152,985 | -1,012 | -68,393 | -52,748 | -380,949 |
| Common Stock Issued | 32,255 | 36,964 | 5,117 | 22,410 | 109,727 |
| Dividend Paid | N/A | N/A | N/A | N/A | -2,430 |
| Other Financing Activity | 0 | -325,946 | -7,083 | -7,642 | 0 |
| Financing Cash Flow | $-120,730 | $330,631 | $-70,359 | $-31,280 | $227,348 |
| Beginning Cash Position | 318,043 | 200,559 | 193,731 | 66,194 | 108,172 |
| End Cash Position | 298,653 | 318,043 | 200,559 | 193,731 | 66,194 |
| Net Cash Flow | $-19,390 | $117,484 | $6,828 | $127,537 | $-41,978 |
| Free Cash Flow | |||||
| Operating Cash Flow | 308,269 | 262,517 | 303,989 | 212,025 | -40,571 |
| Capital Expenditure | -69,209 | -151,359 | -87,466 | -73,384 | -35,504 |
| Free Cash Flow | 239,060 | 111,158 | 216,523 | 138,641 | -76,075 |